Hypoperfusion is a potential inducer of immunosuppressive network in Alzheimer's disease

Antero Salminen1

  • 1Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland.

Insights

Hypoxia in Alzheimer's disease (AD) drives immunosuppression through mechanisms like inflammation and altered immune cell function, supporting the vascular hypothesis of AD. This research explores these links to understand AD pathogenesis.

Area of Science:

  • Neuroimmunology
  • Vascular Biology
  • Neurodegenerative Diseases

Background:

  • Alzheimer's disease (AD) is a progressive neurodegenerative disorder causing irreversible cognitive decline.
  • The etiology of late-onset AD remains largely unknown, despite over a century of research.
  • Emerging evidence supports the vascular hypothesis, linking brain hypoperfusion to AD pathology.

Purpose of the Study:

  • To investigate the role of hypoperfusion and hypoxia in AD pathogenesis.
  • To elucidate the mechanisms by which hypoxia-inducible factor-1α (HIF-1α) modulates immune responses in the context of AD.
  • To explore the association between hypoxia-induced immunosuppression and AD-related immunological changes.

Main Methods:

  • Review and examination of existing literature on hypoxia, inflammation, and AD.
  • Analysis of neuroimaging studies revealing brain hypoperfusion in AD-vulnerable regions.
  • Detailed examination of immunological mechanisms, including HIF-1α signaling, immune cell phenotypes, and exosome secretion.

Main Results:

  • Hypoperfusion and hypoxia are implicated in AD pathology, potentially explaining beta-amyloid deposition and inflammation.
  • Hypoxia-inducible factor-1α (HIF-1α) stimulates inflammatory responses and promotes immunosuppression via multiple pathways.
  • AD pathology exhibits enhanced immunosuppression, characterized by M2 microglia/macrophage shifts and increased regulatory T cells (Tregs).

Conclusions:

  • Hypoxia-induced immunosuppression shares common mechanisms with AD pathogenesis.
  • These immunological findings provide strong support for the vascular hypothesis of Alzheimer's disease.
  • Understanding these links is crucial for developing novel therapeutic strategies for AD.